CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08
Ki Hyang Kim, Joo Hoon Kim, Ji Young Lee, Hyo Song Kim, Su Jin Heo, Ji Hyung Kim, Ho Young Kim, Sun Young Rha
Cancer Research and Treatment. 2016;48(4):1286-1292.   Published online 2016 February 12    DOI: https://doi.org/10.4143/crt.2016.018

Excel Download

Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08
Cancer Research and Treatment. 2016;48(4):1286-1292   Crossref logo
Link1 Link2 Link3

Metastatic Renal Cell Carcinoma: Role of Mammalian Target of Rapamycin Inhibitors
Clinical Genitourinary Cancer. 2007;5(6):359-361   Crossref logo
Link1 Link2

Molecular Pathways in Metastatic Renal Cell Carcinoma: The Evolving Role of Mammalian Target of Rapamycin Inhibitors
European Urology Supplements. 2009;8(10):793-798   Crossref logo
Link1 Link2

Current Data with Mammalian Target of Rapamycin Inhibitors in Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer. 2006;5(2):110-113   Crossref logo
Link1 Link2

Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry
Cancer Research and Treatment. 2019;51(2):758-768   Crossref logo
Link1 Link2 Link3

Use of mammalian target of rapamycin inhibitors after failure of tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma undergoing hemodialysis: A single-center experience with four cases
Hemodialysis International. 2016;20(3):E1-E5   Crossref logo
Link1

A “Game of Thrones” in Metastatic Renal Cell Carcinoma: Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors and Mammalian Target of Rapamycin Inhibitors Battling for Position
Clinical Genitourinary Cancer. 2013;11(1):1-4   Crossref logo
Link1 Link2

MP57-03 SEQUENTIAL USE OF MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA FOLLOWING FAILURE OF TYROSINE KINASE INHIBITORS
Journal of Urology. 2014;191(4S):   Crossref logo
Link1 Link2

Sequential use of mammalian target of rapamycin inhibitors in patients with metastatic renal cell carcinoma following failure of tyrosine kinase inhibitors
Medical Oncology. 2013;30(4):   Crossref logo
Link1 Link2 Link3

Mammalian Targets of Rapamycin Inhibitors: Temsirolimus and Everolimus
Renal Cell Carcinoma. 2017;273-294   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.